Pharmaceutical and biotech manufacturing processes are complex and require well integrated and documented flows of information from upfront forecast demand and customer orders through the production process to inventory receipt and order fulfillment. The components...
For mature markets with retiring "baby boomers", how do we best facilitate the knowledge transfer to the next generation of instrumentation and automation professionals? Emerson's Gary Mitchell, a Senior Life Sciences Industry Consultant, shares some of his career...
Emerson's Jonathan Lustri explores the trend towards continuous manufacturing for solid dose pharmaceuticals and the technologies and practices that make this possible. This past year I have become aware of a very big change that is coming to the pharmaceutical...
While integration technologies have helped bridge "islands of automation" over the years, some process manufacturers still have parts of their automated processes disconnected from the rest. Emerson's Gary Mitchell, a senior industry consultant on the Life Sciences...
In two very different industries, I have some updates to share from Emerson consultants. On the reliability front, when we last checked in with Emerson's Richard Barnes, a Senior Asset Optimization Consultant, he was at a refinery located on the Black Sea, assisting...
Highly regulated industries, such as pharmaceutical and biotech manufacturing, face a myriad of compliance issues, which vary by region of the world and continuously involve. Emerson's Heather Schwalje presented Regulatory Drivers- GMPs 21st Century to Life Science...
The ISA-95 (IEC 62264) Enterprise-Control System Integration (part 1, part 2, part 3, part 4, part 5) international standard provides a model to help define the boundaries between the enterprise systems and process control systems. As manufacturing operations seek to...
Projects to connect your process operations to your business processes and workflows typically require connections with several specialized software platforms. For manufacturers in the pharmaceutical and biotech industries, these electronic connections span the ISA-95...
One of the conversations happening among pharmaceutical and biotech manufacturers is around the "facility of the future". I caught up with Emerson's Gary Mitchell, a consultant on the Life Sciences industry team. He shared some of the trends prompting this relook at...
I wanted to share my guest post over at the PharmaEvolution.com blog, Justifying New Tech Investment When the Plant Is Running Full Out. It can often be challenging to justify investing in new technology when a plant has spare capacity, as Michalle Adkins mentioned...
Models can help bring understanding to complex processes. In batch manufacturing, one of the benefits from generating models from process history data is the process understanding gained by going through the steps of generating and refining the model. These steps...
Justifications for automation investments can be based on many factors—increasing revenues, reducing costs, increasing working capital efficiency, and maximizing the return on fixed capital. How do you justify automation investments from a production process not...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.